Toggle navigation
Home
Search
Services
Blog
Contact
About
Clinical Evaluation of Biological Modifiers
Berd, David
Fox Chase Cancer Center, Philadelphia, PA, United States
Search 18 grants from David Berd
Search grants from Fox Chase Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks
TSE LabMaster - CaloS-Dri/Fed+AC/Act.XY-Tel, 3x8 Mice
Role of Neuronal NOS in Neurotoxicity
Matching of TX Modalities to Adolescent Substance Abuse
Regulation of Transcription During Maturation of Leukemi
Recently added grants:
Roles of TET2-dependent DNA demethylation intermediates in hematological malignancies
Examining Mortality Risk and Cause of Death among California's Newborn Screening Identified Cohort with Sickle Cell Trait
Mechanisms of Erythroid Remission in Diamond Blackfan Anemia (DBA)
Peritoneal Oxygen Delivery For The Treatment Of Acute Respiratory Distress Syndrome
Levetiracetamin in First Episode Psychosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM007432-001005
Application #
3608441
Study Section
Project Start
1983-09-30
Project End
Budget Start
1985-08-01
Budget End
1986-01-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Related projects
NIH 1986
N01 CM
Clinical Evaluation of Biological Modifiers
Berd, David / Fox Chase Cancer Center
NIH 1985
N01 CM
Clinical Evaluation of Biological Modifiers
Berd, David / Fox Chase Cancer Center
Publications
Berd, D; Mastrangelo, M J
(1987)
Depletion of suppressor-cytotoxic T-lymphocytes by administration of a murine monoclonal antibody.
Cancer Res 47:2727-32
Comments
Be the first to comment on this grant